Our data also paves the way for LH GABAergic neurons, among other cell types (perhaps glutamatergic), in the Lateral Hypothalamus to be a potential pharmacological target for developing new appetite suppressants to treat obesity. Here, PLOD1 is linked to obesity disorder.